International Vaccine Institute strategic demand forecasting; and Sabin – communications and advocacy. Besides leading the consortium, IVI generated evidence for decision-making such as disease burden, country vaccine introduction cases and a global investment case. From 2010 to 2016, DVI operated in Brazil, Burkina Faso, Cambodia, Colombia, Gabon, India, Kenya, Thailand, and Vietnam. From 2013-2015, with funding from Germany’s Federal Ministry of Education & Research (BMBF), IVI continued support for preclinical development of dengue vaccines by Brazil’s Butantan Institute and Vietnam’s VaBiotech. After the 2016 licensure of Sanofi Pasteur’s Dengvaxia vaccine, the DVI project came to a close and its IVI staff transitioned to
The North-South Institute The North-South Institute Founded in 1976, The North-South Institute (NSI) is a policy research institution or think tank based in Ottawa, Canada and specializing in international development. The objectives of the institute were as follows: For nearly four decades, NSI endeavored to fulfill these objectives and to pursue the broad goal of reducing global poverty and inequality through effective international development. In think tank rankings, the North-South Institute was recognized as one of the leading think tanks with a budget of less than $5m, and one of the most prominent institutions in Canada. On September 10, 2014, the North-South Institute